B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2018.00264
Abstract: B7H3 (also known as CD276, an immune checkpoint molecule) is aberrantly overexpressed in many types of cancer, and such upregulation is generally associated with a poor clinical prognosis. Recent discoveries indicate a crucial role for… read more here.
Keywords: b7h3; b7h3 promoter; metastasis; cancer ... See more keywords